Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand|
|Citation:||Australian & New Zealand Journal of Obstetrics & Gynaecology, 2013; 53(1):86-89|
|Publisher:||Blackwell Publishing Asia|
|Emily Bain, Tanya Bubner, Pat Ashwood, Caroline A. Crowther and Philippa Middleton|
|Abstract:||Health professionals at 25 Australian and New Zealand tertiary maternity hospitals were surveyed about local implementation of a clinical practice guideline for antenatal magnesium sulphate for fetal neuroprotection. Seventy-six percent of respondents reported that their hospital is currently following a guideline; 36% confirmed that their hospital is auditing uptake. Estimates of uptake ranged from 53 to 90%. Ongoing education and support are needed to ensure that the guidelines are optimally implemented, and uptake and important health outcomes are monitored.|
|Keywords:||antenatal care; clinical practice; guidelines; magnesium sulphate; preterm; survey|
|Description:||for The WISH Project Team|
|Rights:||© 2012 The Authors|
|Appears in Collections:||Obstetrics and Gynaecology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.